Editorial BoardEditor-in-ChiefDavid J. Greenblatt, Tufts University, USA
Managing EditorElizabeth Marshall, Towson, MD
Editorial BoardJoseph S. Bertino, Jr. Schenectady, NY; Bertino Consulting Lawrence J. Botticelli, Cambridge, MA; Lipidion Therapeutics LLC Michael H. Court, Pullman, WA; Washington State University Hartmut Derendorf, Gainesville, FL; University of Florida College of Pharmacy Michael J. Fossler, Chesterbrook, PA; Trevena, Inc. Kenneth I. Kaitin, Boston, MA; Tufts University School of Medicine Donald E. Mager, Buffalo, NY; University of Buffalo John S. Markowitz, Gainesville, FL; University of Florida Gerd Mikus, Heidelberg, Germany; University of Heidelberg Diane R. Mould, Phoenixville, PA; Projections Research Inc. Amin Rostami-Hodjegan, Manchester, United Kingdom; University of Manchester Edward M. Sellers, Toronto, Ontario, Canada; University of Toronto and DL Global Partners, Inc. Daniel S. Sitar, Winnipeg, Manitoba, Canada; University of Manitoba Phil Skolnick, Bethesda, MD; National Institute on Drug Abuse Karthik Venkatakrishnan, Cambridge, MA; Takeda Pharmaceuticals International Co. Lisa L. von Moltke, Waltham, MA; Alkermes, Inc. Joan M. Korth-Bradley, Collegeville, PA; Pfizer, Inc. Darrell R. Abernethy (Food and Drug Administration), founding Editorial Board member, passed away in November 2017. Dr. David A. Flockhart (University of Indiana School of Medicine), founding Editorial Board member, passed away in November 2015.
|